Clinical Trial: Early Administration of Angong Niuhuang Pill for Disabling Acute Ischemic Stroke (EAGER Trial)

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07882030) titled 'Early Administration of Angong Niuhuang Pill for Disabling Acute Ischemic Stroke (EAGER Trial)' on Sept. 27.

Brief Summary: This multicenter, prospective, randomized, double-blind, placebo-controlled clinical trial is designed to evaluate the efficacy and safety of early administration of Angong Niuhuang Pill in patients with disabling acute ischemic stroke.

Approximately 1,200 eligible participants will be randomly assigned in a 1:1 ratio to receive Angong Niuhuang Pill or a matching placebo for 5 consecutive days. Eligible participants will be adults aged 18 to 80 years with imaging-confirmed acute ischemic stroke involving the a...